Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Dube Michael P. Director active across 1 company, notably Intellia Therapeutics, Inc.. Cumulatively, 6 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €111k. Activity tracked since 1 July 2024. The latest transaction was filed on 1 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Dube Michael P is a declarant linked to Intellia Therapeutics, Inc., where he serves as VP, Chief Accounting Officer. He has 5 filings in total, and among the recent filings observed between 2024-07-03 and 2026-07-06, they show EUR 89842 of sales and EUR 0 of purchases, with the dominant transaction nature shown as sell.